Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph...
-
Upload
lambert-baker -
Category
Documents
-
view
216 -
download
1
Transcript of Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph...
![Page 1: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/1.jpg)
Allomed Pharmaceuticals
D-Chiro-Inositol and its Role in Diabetes
and Insulin Resistance
Joseph Larner
![Page 2: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/2.jpg)
The Search for an Insulin Mediator • Two Enzyme Bioassays
• Initial Mediator Hypothesis and Search• Inositol Glycans Isolated from Rat Liver• Scale up to Beef Liver• Isolate and Determine Novel Structure of Pinitol Galactosamine Pseudodisaccharide Mn++ Chelate
o Bioactivity of Synthetic Pseudodisaccharide• Theoretical Docking and Allosteric Mechanism of Action of Pseudodisaccharide to Activate PP2C• Pathophysiology of Inositol Imbalance and Relation to Insulin Resistance• Epimerization Defect• Repletion with D-Chiro-Inositol• Future New Possible Therapeutic Agents:
o Dibutyryl D-Chiro-Inositolo Pseudodisaccharideo Modified Pseudodisaccharide
![Page 3: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/3.jpg)
![Page 4: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/4.jpg)
PD
H (
% M
axim
um
Act
ivit
y)
![Page 5: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/5.jpg)
![Page 6: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/6.jpg)
TLC chromatogram of 2 purified inositol glycans from rat liver. TLC plate developed in isopropanol:pyridine:acetic acid:H2O (8:8:1:4) sprayed with ninhydrin. Lanes 1 and 4, galactosamine standards; Lane 5, PDH phosphatase stimulator from control rat; Lane 6, PDH phosphatase stimulator from insulin treated rat; Lane 2, cAMP-kinase inhibitor from control rat; Lane 3, cAMP-kinase inhibitor from insulin treated rat.
![Page 7: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/7.jpg)
![Page 8: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/8.jpg)
![Page 9: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/9.jpg)
TLC analysis of silica column fractions from beef liver. Aliquots of fractions 1,2,3 eluted from silica column, stained with ninhydrin together with a galactosamine standard are shown. Solvent used contained pyridine: isopropanol:acetic acid:water (8:8:1:4). Lane 1 – galactosamine standard; lanes 2,3,4 fractions 1,2,3 eluated from the silica column. Note the higher Rf peach staining
spots in lanes 2,3 most prominent in lane 3 separated from the heavier blue ninhydrin staining peptide material in lane 4, fraction 3.
1 2 3 4Allomed Pharmaceuticals
![Page 10: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/10.jpg)
![Page 11: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/11.jpg)
Allomed
Pharmaceuticals 0 15 30 45 60 75 90 105 120 135
40
60
80
100
120
Saline (n=6)
-INS-2 (n=4)
-INS-2 (n=6)
***
Time (min)
Pla
sm
a G
luco
se (
% o
f Z
ero
Tim
e)
![Page 12: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/12.jpg)
Allomed
Pharmaceuticals 0 20 40 60 80 100 120 140
0
20
40
60
80
100
120
140
* +
*
+
oo
*
+
*
*
*
**
***
*
Saline (n=10)
INS-2 2 mg/kg (n=6)
INS-2 8 mg/kg (n=6)INS-2 20 mg/kg (n=5)
o
Time (min)
Pla
sm
a G
luc
os
e (
% o
f Z
ero
Tim
e)
![Page 13: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/13.jpg)
10 -5 10 -4 10 -3 10 -2 10 -1 1 100
10000
20000
30000
40000
50000
* * **
* *
INS2 alone
INS2 with 10nM Insulin
INS-2 Concentration (mM)
[14 C
] G
luc
os
e I
nc
orp
ora
tio
n i
nto
[1
4 C]
Gly
co
ge
n (
CP
M)
Allomed Pharmaceuticals
![Page 14: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/14.jpg)
10 -6 10 -5 10 -4 10 -3 10 -2 10 -1 1 10 1000
10
20
30
40
50
60
70
*
**
INS2
Mn++
INS2-Mn++
Basal
INS-2 Mn++ Chelate or Mn++ Concentration(mM)
PD
H P
ho
sp
ha
tas
e R
ea
cti
on
Ve
loc
ity
(a
rbit
rary
un
its
)
Allomed Pharmaceuticals
![Page 15: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/15.jpg)
Allosteric site
Catalytic site
![Page 16: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/16.jpg)
Pseudodisaccharide
![Page 17: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/17.jpg)
Phosphorylated peptide substrate
Pseudodisaccharide
Asp 243
![Page 18: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/18.jpg)
ANALYSIS OF INS2 BINDING INTERACTIONS
Using FlexX to find the highest affinity binding conformation, Sybyl was then used to analyze the hydrogen bonding of this conformation of INS2 to PP2C. As we expected, INS2 has strong hydrogen bonding interactions with Asp 243 from two points in the molecule. It was also found that INS2 had a similar interaction with Asp 163. The site mutagenesis data at 163 showing 50% reduced activity upon the removal of this residue helps to support our binding hypothesis for INS2.
![Page 19: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/19.jpg)
Mutations in catalytic site
Mutations in allosteric site
SITE POINT MUTAGENESIS OF PP2C
![Page 20: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/20.jpg)
Pathophysiology of Inositol Imbalance and
Relation to Insulin Resistance
![Page 21: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/21.jpg)
![Page 22: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/22.jpg)
Control Subjects
Type II Diabetic Subjects
![Page 23: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/23.jpg)
Urin
ary
Exc
retio
n of
Ino
sito
ls(µ
mol
/day
± S
EM
)
UVA Pima Indian Subjects
![Page 24: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/24.jpg)
Urin
ary
Inos
itol E
xcre
tion
(nm
ol/d
ay)
Wistar Rats GK rats
![Page 25: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/25.jpg)
![Page 26: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/26.jpg)
![Page 27: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/27.jpg)
![Page 28: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/28.jpg)
![Page 29: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/29.jpg)
Myo-Inositol to Chiro-Inositol
Epimerization Defect
![Page 30: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/30.jpg)
• Conversion of Myo-Inositol to
Chiro-Inositol is defective
in diabetes.
![Page 31: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/31.jpg)
Future New Possible Therapeutic Agents
![Page 32: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/32.jpg)
![Page 33: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/33.jpg)
![Page 34: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/34.jpg)
![Page 35: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/35.jpg)
![Page 36: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/36.jpg)
![Page 37: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/37.jpg)
-13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -30
20
40
60
80
100 Diabetic + Saline
Diabetic + D-chiro-inositol
Euglycemic + Saline
*#
*#*
*
#*
Acetylcholine (log M)
Rel
axat
ion
(%
Ph
e)
![Page 38: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/38.jpg)
-10 -9 -8 -7 -6 -5 -4 -3 -20
20
40
60
80
100
Diabetic + salineDiabetic + D-chiro-inositol
* * * ** *
Normoglycemic
Acetylcholine (- Log M)
Per
fusi
on P
ress
ure
(% P
he)
![Page 39: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/39.jpg)
-17 -16 -15 -14 -13 -12 -11 -10 -9 -8 -7 -6 -50
20
40
60
80
100
Diabetic + saline
Diabetic + D-chiro-inositol
Normoglycemic
*
Sodium Nitroprusside (log M)
Rel
axat
ion
(%Ph
e)
![Page 40: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/40.jpg)
0.1 1 10 100 10000
20
40
60
80
100
Diabetic + saline
Diabetic + D-chiro-inositol
Normoglycemic
*
NO (M)
Rel
axat
ion
(%Ph
e)
![Page 41: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/41.jpg)
-11 -10 -9 -8 -7 -6 -5 -4 -3-100
-75
-50
-25
0
Euglycemic + vehicleDiabetic + vehicleDiabetic + Allo-1
** * *
* * *
Acetylcholine (Log M)
Dec
reas
e in
Per
fusi
on P
ress
ure
(%)
![Page 42: Allomed Pharmaceuticals D-Chiro-Inositol and its Role in Diabetes and Insulin Resistance Joseph Larner.](https://reader030.fdocuments.in/reader030/viewer/2022032606/56649e875503460f94b8b596/html5/thumbnails/42.jpg)
Suppression by D-Chiro-Inositol and Allo-1 of ROSconcentrations in Bovine Aortic Endothelial Cells
Incubated in the presence of 30 mM Glucose
5 m
M G
luco
se
30 m
M G
luco
se
20 µ
M C
hir
o
50 µ
M C
hir
o
100
µM
Ch
iro
20 µ
M A
llo
-1
50 µ
M A
llo
-1
100
µM
All
o-1
0
50
100
150
200
250
*
* **
* *
**
RO
S (
nm
ole
s/m
L)